Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SOPHIA ANTIPOLIS, France, July 5, 2016 (GLOBE NEWSWIRE) -- On July 4, 2016, Nicox S.A. (« Nicox ») and a company controlled by GHO Capital (the « Partner »)...
-
SOPHIA ANTIPOLIS, France, Feb. 3, 2016 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: FR0013018124, COX) today announced that Michele Garufi, Chairman and CEO of Nicox, will be presenting at the 18th...
-
LAVAL, Quebec and SOPHIA ANTIPOLIS, France, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, and...
-
Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in Europe
InSite grants Nicox exclusive license for AzaSite® (1% azithromycin), BromSite(TM) (0.075% bromfenac) and AzaSite Xtra(TM) (2% azithromycin) in Europe, Middle East and Africa European...
-
Sophia Antipolis, Valbonne, France, Oct. 9, 2014 (GLOBE NEWSWIRE) -- This press release is being re-issued with a corrected forward-looking statement. Nicox continues expansion of international...
-
SOPHIA ANTIPOLIS, France, Sept. 26, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX) today announced the completion of the acquisition of Doliage, a privately-held French ophthalmic...
-
Meets Primary Endpoint in Phase 3 Studies Expect to file in the U.S. in First Half of Q2 2015 Expect to launch in the U.S. in First Half of 2016 Peak US sales ~$500 million+, Peak Global Sales...
-
Acquires full rights from Marinomed Biotechnologie to Carragelose® anti-viral eye drop for potential application in the management of viral conjunctivitis Potential for European launch...
-
SOPHIA ANTIPOLIS, France, Aug. 29, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced that it has entered into an exclusive agreement...
-
Nicox gains expanded North American rights for Sjö(TM) from Immco Diagnostics ................................... Nicox acquires extension of rights to market Sjö(TM) to all...